#SCIREQ

SCIREQ an EMKA TECH Company

@scireq.bsky.social

1 month ago

Precision Particles for Persistent Asthma A promising solution for Asthma: an innovative dry powder for inhalation (DPI) designed for controlled release and prolonged lung retention.

Our latest blog explores the details of recent research from Le Van Bui (2025) that offers a promising solution for a longstanding problem for Asthma patients Read the full blog here: hubs.ly/Q03-Yy5M0

#AsthmaStudies #PulmonaryResearch #SCIREQ #emkaTechnologies #vivoFlow #plethysmography

SCIREQ an EMKA TECH Company

@scireq.bsky.social

3 months ago

Breathing Life into Nanodrug Research: A Lung-on-Chip Revolution Traditional aerosol exposure systems often fall short in replicating the complex dynamics of human breathing in a controlled lab setting.

A recent study by Wang et al. (2024) explores how nanodrug carriers, such as liposomes, behave under different breathing conditions. Read the full blog here: hubs.ly/Q03XQT8k0

#SCIREQ #LungonChip #nanoDrug #respiratoryResearch #inExpose

emka TECHNOLOGIES

@emkatech.bsky.social

9 months ago

We are at the MPS World Summit in Brussel this week!
Visit David Brunet and Emad Yacoub at our booth #424 to explore our solutions for ex vivo and in vitro studies: www.emkatech.com/news/msws-20...

#MPS25 #expoCube #physioLens #PCLS #ALI #SCIREQ #emkaBATH

SCIREQ an EMKA TECH Company

@scireq.bsky.social

10 months ago

It is day 1 of the 2025 #APSSummit
Swing by booth #912 to meet our experts and discuss your latest research !

#SCIREQ #emka #PhysiologyResearch #APS2025

SCIREQ an EMKA TECH Company

@scireq.bsky.social

10 months ago

Swing by our booth at the BIOTECH CONNECT Expo next Thursday in Montreal ! Our team is excited to meet you and explore all the new local innovation and research projects 🔬🔎

#SCIREQ #RespiratoryResearch #Montreal

SCIREQ an EMKA TECH Company

@scireq.bsky.social

11 months ago

Treating Acute Inflammatory Lung Disease: The Promise of Trimannose-Coupled antimiR-21 Recent advances in the fight against severe acute inflammatory lung diseases, including COVID-19, have revealed a promising new approach to treating pulmonary hyperinflammation and long-term lung dama...

This recent blog features a study by Beck et al (2023) which developed a first-in-class, carbohydrate-coupled inhibitor of microRNA-21 (RCS-21), that shows significant potential as a therapeutic agent: www.scireq.com/treating-acu...

#LungFunction #FlexiVent #SCIREQ

SCIREQ an EMKA TECH Company

@scireq.bsky.social

11 months ago

Congratulations to Kolawole Adesina on winning the #SOT2025 IRSS emka-SCIREQ Award for his Respiratory Academic Research !

#ToxExpo2025 #AcademicAwards #RespiratoryResearch #emkaSCIREQ #SCIREQ

SCIREQ an EMKA TECH Company

@scireq.bsky.social

11 months ago

It is Day 1 of hashtag#ToxExpo2025, head over to booths 1140 & 1142 to meet our Cardio and Respiratory experts and discuss your latest studies !

#emkaTech #SCIREQ #Cardio #RespiratoryResearch #CardioPulmonary #SOT2025

emka TECHNOLOGIES

@emkatech.bsky.social

11 months ago

It is Day 1 of #ToxExpo2025, head over to booths 1140 & 1142 to meet our Cardio and Respiratory experts and discuss your latest studies !

#emkaTech #SCIREQ #Cardio #RespiratoryResearch #CardioPulmonary #SOT2025